Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pacific Biosciences (PACB)
NASDAQ:PACB
Pacific Biosciences (PACB) Stock Forecast & Price Target
2,249 Followers
See the Price Targets and Ratings of:
PACB Analyst Ratings
Moderate Buy
3 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PACB Stock 12 Month Forecast
Average Price Target
$3.71
▲(123.49% Upside)
| Highest Price Target$8.00 | Average Price Target$3.71 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Barclays
Reiterated
06/28/24
Jefferies
Initiated
06/03/24
Piper Sandler
Assigned
05/13/24
Scotiabank
Reiterated
05/13/24
Morgan Stanley
Assigned
05/13/24
Goldman Sachs
Reiterated
05/10/24
Canaccord Genuity
Reiterated
05/10/24
J.P. Morgan
Downgraded
04/21/24
Bernstein
Reiterated
04/18/24
TD Cowen
Reiterated
04/17/24
Nephron
$2
Hold
$2.00
(20.48% Upside)
Downgraded
04/16/24
Nephron downgrades Pacific Biosciences of California (PACB) to HoldNephron analyst Jack Meehan downgraded Pacific Biosciences of California (NASDAQ: PACB) from Buy to Hold with a price target of $2.00.
UBS
$12.5→$12
Buy
$12.00
(622.89% Upside)
Reiterated
02/16/24
Pacific Biosciences of California (PACB) PT Lowered to $12 at UBSUBS analyst John Sourbeer lowered the price target on Pacific Biosciences of California (NASDAQ: PACB) to $12.00 (from $12.50) while maintaining a Buy rating.
Cantor Fitzgerald
$11→$9
Buy
$9.00
(442.17% Upside)
Reiterated
02/16/24
Pacific Biosciences of California (PACB) PT Lowered to $9 at Cantor FitzgeraldCantor Fitzgerald analyst Ross Osborn lowered the price target on Pacific Biosciences of California (NASDAQ: PACB) to $9.00 (from $11.00) while maintaining a Overweight rating.
Stephens
$11
Buy
$11.00
(562.65% Upside)
Assigned
12/13/23
PacBio initiated with bullish view at Stephens, here's whyPacBio initiated with bullish view at Stephens, here's why
Wolfe Research
―
Hold
―
Initiated
12/12/23
PacBio initiated with neutral view at Wolfe ResearchPacBio initiated with neutral view at Wolfe Research
Best Analysts Covering Pacific Biosciences
Which Analyst Should I Follow If I Want to Buy PACB and Sell After:
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+7.67%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +7.67% per trade.
3 Months
xxx
Success Rate
4/7 ratings generated profit
Average Return
-6.49%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of -6.49% per trade.
1 Year
Success Rate
5/16 ratings generated profit
Average Return
+13.83%
reiterated a buy rating 2 months ago
Copying Kyle Mikson CFA's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of +13.83% per trade.
2 Years
xxx
Success Rate
1/7 ratings generated profit
Average Return
-56.44%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -56.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PACB Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
8
9
13
8
8
Buy
2
1
0
0
0
Hold
6
4
7
8
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
14
20
16
17
Each month's total comprises the sum of three months' worth of ratings.
PACB Financial Forecast
PACB Stock Forecast FAQ
What is PACB’s average 12-month price target, according to analysts?
Based on analyst ratings, Pacific Biosciences’s 12-month average price target is $3.71.
What is PACB’s upside potential, based on the analysts’ average price target?
Pacific Biosciences has 123.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PACB a Buy, Sell or Hold?
Pacific Biosciences has a consensus rating of Moderate Buy which is based on 3 buy ratings, 4 hold ratings and 0 sell ratings.
What is Pacific Biosciences’s price target?
The average price target for Pacific Biosciences is $3.71. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $2.00. The average price target represents 123.49% Increase from the current price of $1.66.
The highest analyst price target is $8.00 ,the lowest forecast is $2.00. The average price target represents 123.49% Increase from the current price of $1.66.
What do analysts say about Pacific Biosciences?
Pacific Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of PACB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.